Obesity and male breast cancer: provocative parallels?

被引:26
|
作者
Humphries, Matthew P. [1 ]
Jordan, V. Craig [2 ]
Speirs, Valerie [1 ]
机构
[1] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Breast Med Oncol & Mol & Cellular Oncol, Houston, TX 77030 USA
来源
BMC MEDICINE | 2015年 / 13卷
关键词
Aromatase; Aromatase inhibitor; Body mass index; Estrogen; Incidence; Male breast cancer; Obesity; Risk factor; Selective estrogen receptor modulator; Tamoxifen; BODY-MASS INDEX; ADIPOSE-TISSUE; HYPOGONADOTROPIC HYPOGONADISM; GONADOTROPIN-SECRETION; AROMATASE INHIBITORS; POSTMENOPAUSAL WOMEN; SEX-HORMONES; RISK-FACTORS; MEN; ESTROGEN;
D O I
10.1186/s12916-015-0380-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While rare compared to female breast cancer the incidence of male breast cancer (MBC) has increased in the last few decades. Without comprehensive epidemiological studies, the explanation for the increased incidence of MBC can only be speculated. Nevertheless, one of the most worrying global public health issues is the exponential rise in the number of overweight and obese people, especially in the developed world. Although obesity is not considered an established risk factor for MBC, studies have shown increased incidence among obese individuals. With this observation in mind, this article highlights the correlation between the increased incidence of MBC and the current trends in obesity as a growing problem in the 21st century, including how this may impact treatment. With MBC becoming more prominent we put forward the notion that, not only is obesity a risk factor for MBC, but that increasing obesity trends are a contributing factor to its increased incidence.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Obesity and male breast cancer: provocative parallels?
    Matthew P. Humphries
    V. Craig Jordan
    Valerie Speirs
    BMC Medicine, 13
  • [2] Obesity as potential breast cancer risk factor for postmenopausal women
    Mohanty, Swati Sucharita
    Mohanty, Prafulla Kumar
    GENES & DISEASES, 2021, 8 (02) : 117 - 123
  • [3] Obesity and endocrine therapy: Host factors and breast cancer outcome
    Goodwin, Pamela J.
    BREAST, 2013, 22 : S44 - S47
  • [4] The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women
    Turkoz, F. P.
    Solak, M.
    Petekkaya, I.
    Keskin, O.
    Kertmen, N.
    Sarici, F.
    Arik, Z.
    Babacan, T.
    Ozisik, Y.
    Altundag, K.
    JOURNAL OF BUON, 2013, 18 (02): : 335 - 341
  • [5] Obesity and Angiolymphatic Invasion in Primary Breast Cancer
    Gillespie, Erin F.
    Sorbero, Melony E.
    Hanauer, David A.
    Sabel, Michael S.
    Herrmann, Emily J.
    Weiser, Laura J.
    Jagielski, Christina H.
    Griggs, Jennifer J.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) : 752 - 759
  • [6] The Challenges of Treating Patients with Breast Cancer and Obesity
    LeVee, Alexis
    Mortimer, Joanne
    CANCERS, 2023, 15 (09)
  • [7] The Association between Obesity and Premenopausal Breast Cancer According to Intrinsic Subtypes - a Systematic Review
    Torres-de la Roche, Luz Angela
    Steljes, Isabell
    Janni, Wolfgang
    Friedl, Thomas W. P.
    De Wilde, Rudy Leon
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : 601 - 610
  • [8] The endocrinology of male breast cancer
    Fentiman, Ian S.
    ENDOCRINE-RELATED CANCER, 2018, 25 (06) : R365 - R373
  • [9] Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
    Eggemann, Holm
    Ignatov, Atanas
    Smith, Bobbie J.
    Altmann, Udo
    von Minckwitz, Gunter
    Roehl, Freidrich W.
    Jahn, Mark
    Costa, Serban-Dan
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 465 - 470
  • [10] Obesity-associated Breast Cancer: Analysis of risk factors
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 571 - 606